Heart, COVID-19, and echocardiography

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Coronavirus disease 2019 (COVID-19) primarily presents with respiratory symptoms, but significant cardiovascular damage is increasingly recognized.
• Previous outbreaks, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), demonstrated links between cardiovascular metabolic diseases and respiratory illness.
• Many COVID-19 patients exhibit comorbidities like hypertension, cardio-cerebrovascular disease, and diabetes, elevating their mortality risk.

Purpose of the Study:

• To review the cardiovascular effects of the 2019 novel coronavirus (2019-nCoV).
• To synthesize current literature on COVID-19's cardiovascular impact, drawing parallels with SARS and MERS.
• To analyze the potential utility of echocardiography in managing COVID-19 patients during acute illness and follow-up.

Main Methods:

• Comprehensive literature review of recent studies on COVID-19 and cardiovascular effects.
• Analysis of existing data from SARS and MERS outbreaks concerning cardiovascular comorbidities.
• Evaluation of the role of echocardiography in diagnosis and management.

Main Results:

• COVID-19 can lead to direct myocardial injury, arrhythmias, and thromboembolic events.
• Comorbidities significantly increase the risk of severe COVID-19 and adverse cardiovascular outcomes.
• Echocardiography can identify cardiac dysfunction and guide therapeutic strategies.

Conclusions:

• Cardiovascular complications are a critical aspect of COVID-19, impacting patient prognosis.
• Understanding the cardiovascular effects of 2019-nCoV is crucial for effective clinical management.
• Echocardiography serves as a valuable tool for assessing and monitoring cardiac health in COVID-19 patients.